During the past decade, Andrew and Patel Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Andrew and Patel Associates" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Tumors With Aberrations in ALK or ROS1" (1 trials). Many other conditions were trialed in "Andrew and Patel Associates" in a lesser frequency.

Most popular intervention types in "Andrew and Patel Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ceritinib" (1 trials) and "INC280 (capmatinib)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Andrew and Patel Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Andrew and Patel Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Andrew and Patel Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Andrew and Patel Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".